EMAMILTDNSEEmami Limited· Personal CareHighNeutral
Announced Fri, 16 May · 14:43 IST

Emami Limited has informed the Exchange regarding Outcome of Board Meeting held on May 16, 2025 - Approval of Standalone and Consolidated Audited Financial Results for the quarter and Year ended 31st March, 2025

Ebitda Margin ExpansionResults View source PDF

EMAMILTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Emami's board approved its audited consolidated and standalone financial results for Q4 and FY ended March 31, 2025, with the auditor issuing an unmodified (clean) opinion. For FY25, consolidated revenue from operations rose to Rs. 3,80,919 crore (up ~6.5% from Rs. 3,57,809 crore in FY24), while EBITDA grew to Rs. 1,09,322 crore (up ~9.7%) and profit after tax climbed to Rs. 80,274 crore (up ~10.9%), with EPS at Rs. 18.48. Operating cash flow was healthy at Rs. 89,588 crore. The board also declared a special 3rd interim dividend of Rs. 2 per share (200%) to mark Emami's 50th anniversary, on top of two earlier interim dividends of Rs. 4 each, taking total dividends for FY25 to Rs. 10 per share. Additionally, the company appointed new secretarial auditors, internal auditor, and an interim company secretary, and announced its 42nd AGM for August 29, 2025.

Likely market impact

Strong earnings growth, expanding margins, robust cash generation, and a generous total dividend payout of Rs. 10 per share for FY25 are positive signals for shareholders. The clean audit report and healthy balance sheet (low borrowings of Rs. 6,208 crore vs. equity of Rs. 2,69,479 crore) reinforce confidence, though the stock may see limited upside surprise given results appear largely in line with expectations.